Abstract
Circulating level of adiponectin, an adipocyte-derived protein, is reduced in states of insulin resistance such as obesity and type 2 diabetes. We have previously shown that hypoadiponectinemia is related to insulin resistance in essential hypertension. Recent studies have shown that normotensive subjects with a positive family history of essential hypertension (FH+) have decreased insulin sensitivity compared to subjects with a negative family history of essential hypertension (FH-). We here examined the association between adiponectin concentration and insulin sensitivity in FH+ and FH-. Thirty young, non-obese and normotensive men without a family history of diabetes mellitus were enrolled. A total of 15 subjects were FH+, and the remaining 15 subjects were FH-. Insulin sensitivity index (ISI) was evaluated by the euglycemic hyperinsulinemic glucose clamp technique. Concentrations of adiponectin and other metabolic variables were measured. The FH+ group had significantly lower levels of ISI and adiponectin than did the FH- group. In all of the subjects, ISI was positively correlated with adiponectin concentration and high-density lipoprotein (HDL) cholesterol level and was negatively correlated with insulin level. Adiponectin concentration was the only independent determinant of ISI in a multiple regression analysis. Our results showed that adiponectin level was significantly decreased and that this was accompanied by reduced insulin sensitivity in young, non-obese and normotensive men with a family history of essential hypertension. Phenotype of reduced adiponectin level as an earlier penetrance may be especially useful in genetic analyses of insulin resistance and essential hypertension.
Similar content being viewed by others
Article PDF
References
Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF : A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746–26749.
Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K : cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286–289.
Hu E, Liang P, Spiegelman BM : AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697–10703.
Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M : Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 1996; 120: 803–812.
Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83.
Ouchi N, Kihara S, Arita Y, et al: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476.
Weyer C, Funahashi T, Tanaka S, et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–1935.
Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599.
Furuhashi M, Ura N, Moniwa N, et al: Possible impairment of transcardiac utilization of adiponectin in patients with diabetes mellitus. Diabetes Care 2004; 27: 2217–2221.
Furuhashi M, Ura N, Higashiura K, et al: Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003; 42: 76–81.
Furuhashi M, Ura N, Takizawa H, et al: Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J Hypertens 2004; 22: 1977–1982.
Yamauchi T, Kamon J, Waki H, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941–946.
Okamoto Y, Kihara S, Ouchi N, et al: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767–2770.
Murakami H, Ura N, Furuhashi M, Higashiura K, Miura T, Shimamoto K : Role of adiponectin in insulin-resistant hypertension and atherosclerosis. Hypertens Res 2003; 26: 705–710.
Reaven GM : Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.
Kaplan NM : The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514–1520.
DeFronzo RA, Ferrannini E : Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194.
Iimura O : Insulin resistance and hypertension in Japanese. Hypertens Res 1996; 19 (Suppl) 1: S1–S8.
Lind L, Berne C, Lithell H : Prevalence of insulin resistance in essential hypertension. J Hypertens 1995; 13: 1457–1462.
Facchini F, Chen YD, Clinkingbeard C, Jeppesen J, Reaven GM : Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 1992; 5: 694–699.
Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Otsuka K, Saruta T : Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens 1993; 11: 421–426.
Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM : Insulin resistance in offspring of hypertensive parents. BMJ 1993; 307: 92–96.
Endre T, Mattiasson I, Hulthen UL, Lindgarde F, Berglund G : Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens 1994; 12: 81–88.
Grandi AM, Gaudio G, Fachinetti A, et al: Hyperinsulinemia, family history of hypertension, and essential hypertension. Am J Hypertens 1996; 9: 732–738.
Grandi AM, Gaudio G, Fachinetti A, et al: Insulin sensitivity in obese normotensive adults: influence of family history of hypertension. Int J Obes Relat Metab Disord 1998; 22: 910–914.
Pellme F, Smith U, Funahashi T, et al: Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003; 52: 1182–1186.
DeFronzo RA, Tobin JD, Andres R : Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–E223.
Maeda N, Takahashi M, Funahashi T, et al: PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094–2099.
Yang WS, Jeng CY, Wu TJ, et al: Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002; 25: 376–380.
Miyazaki Y, Hirata A, Murakami H, et al: Effects of aging on the insulin actions for the glucose metabolism and renal function in normotensives and essential hypertensives. Am J Hypertens 1998; 11: 1056–1064.
Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G : Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002; 25: 971–976.
Mohlig M, Wegewitz U, Osterhoff M, et al: Insulin decreases human adiponectin plasma levels. Horm Metab Res 2002; 34: 655–658.
Yamamoto Y, Hirose H, Saito I, et al: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 2002; 103: 137–142.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Furuhashi, M., Ura, N., Higashiura, K. et al. Low Adiponectin Level in Young Normotensive Men with a Family History of Essential Hypertension. Hypertens Res 28, 141–146 (2005). https://doi.org/10.1291/hypres.28.141
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.141
Keywords
This article is cited by
-
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses
Hypertension Research (2023)
-
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Archives of Gynecology and Obstetrics (2017)
-
Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation
American Journal of Hypertension (2012)
-
Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension
Journal of Thrombosis and Thrombolysis (2009)
-
The effects of exercise on haemodynamic function in relation to the familial hypertension risk model
Journal of Human Hypertension (2006)